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ABSTRACT
Objective: Breadfruit leaf has potent antibacterial properties that could be used to reduce biofilms in the oral cavity. The purpose of this study was to 
analyze the antibacterial effect of the breadfruit leaf extract on the growth of Streptococcus mutans in vitro.
Methods: S. mutans ATCC 25175 was cultured in a 96-well plate and incubated at 37°C for 20 h (accumulation phase) and 24 h (maturation phase). 
The breadfruit leaf extract was added at the following concentrations: 5%, 10%, 15%, 20%, 40%, 80%, and 100%. The viability of S. mutans was tested 
with the MTT assay at a wavelength of 490 nm. The results were analyzed by one-way analysis of variance.
Results: In the accumulation phase, a significant decrease was found in S. mutans viability at different concentrations of the breadfruit leaf extract, but 
in the maturation phase, a significant decrease was found in the S. mutans viability at the 5% concentration. The other groups decreased significantly 
compared with the control group (*p<0.05). The viability of S. mutans after adding the breadfruit leaf extract at all concentrations was lower in the 
accumulation phase than that in the maturation phase.
Conclusion: In the accumulation phase, breadfruit leaf extract at concentrations of 5%, 10%, 20%, 40%, 80%, and 100% can reduce S. mutans biofilm 
viability.
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INTRODUCTION
Medicinal plants are natural materials derived from plants that are 
traditionally used by communities but have not been scientifically 
tested. They significantly improve community health when they are 
used in the correct doses, implementation, and time. A medicinal plant 
with considerable potential for human health is Artocarpus altilis, also 
known as breadfruit [2].
Breadfruit is distributed throughout the tropics and its tree is sturdy, 
tall, and leafy [2]. Its fruit is used as food and its leaves have been used 
to treat various diseases such as kidney disease, diabetes mellitus, high 
cholesterol, and canker sores [3].
Streptococcus mutans is a Gram-positive, non-motile, and an anaerobic 
facultative bacterium that plays an important role in the formation of 
biofilms in the oral cavity [4]. The first phase of biofilm formation is 
known as the 0–4 h adhesion phase, during which S. mutans is able 
to attract other microorganisms. The maturation phase happens after 
20 h, during which S. mutans releases a glycosyltransferase enzyme 
that causes the glucose polymerization of sucrose by releasing fructose. 
Glucose is then converted to lactic acid. When a large amount of lactic 
acid is created, they decrease the pH to a critical value of 5.5, causing 
dental demineralization [5-7].
In dentistry, antibacterial compounds are used to decrease plaque 
accumulation. Abdassah et al. stated that the phytochemical of the 
breadfruit leaf extract contains active antibacterial compounds, such 
as flavonoid, polyphenol, quinone, steroid, saponin, monoterpene, 
and sesquiterpene, making our study important [8]. Breadfruit leaf 
was extracted by maceration using 70% ethanol as a solvent [8]. The 
antibacterial activity of breadfruit leaf depends on the concentration 
and contact time of the antibacterial compound [9]. The purpose of 
this study was to analyze the antibacterial effect of the breadfruit leaf 
extract on the viability of S. mutans biofilm at different concentrations 
and contact times.
METHODS
S. mutans ATCC 25175 was obtained from the Oral Biology Laboratory, 
Faculty of Dentistry, Universitas Indonesia, Indonesia, where the study 
was conducted. The sample of the breadfruit leaf extract was obtained 
from the Medicinal and Aromatic Medicine Research Halls (BALITRO), 
Bogor, Indonesia. Artificial saliva was obtained from the Biochemistry 
Laboratory of the Faculty of Medicine, Universitas Indonesia, Indonesia. 
In this study, the positive control used was 0.2% chlorhexidine and BHI 
broth was added with a ratio of 1:1. The viability of S. mutans was tested 
with the MTT assay at a wavelength of 490 nm.
Preparation of S. mutans main solution
The main solution of S. mutans was prepared by taking some bacterial 
colonies grown on BHI agar and placing in a reaction tube containing 
10 mL of BHI broth. The reaction tube was placed in an anaerobic jar 
filled with NO2 and 5% CO2 gas and incubated for 24 h at 37°C.
Making of various concentrations of the breadfruit leaf extract
The breadfruit leaf extract was filtered using a 10-mL syringe and a 
0.2-mm diameter Minisart. This was necessary to filter the portion of 
the breadfruit leaf extract that may interfere in reading the OD value. 
The breadfruit leaf extract was prepared at concentrations of 5%, 
10%, 20%, 40%, 80%, and 100%. The artificial saliva was composed of 
12 mM NaCl, 3.4 mM KSCN, 17.8 mM NaHCO3, 1.5 mM Na2HPO4, 1.5 mM 
KH2PO4, and 2.2 mM urea in an aqueous solvent.
Biofilm formation was performed first in 96-well plates by adding 
100 µL of artificial saliva in each well. The plates were then incubated 
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for 90 min at 37°C. Saliva not attached to the well base was removed 
and wells were washed with 100 µL PBS. Then, 100 µL of diluted and 
standardized bacteria with a concentration of 106 CFU/mL=0.061 
was added to the 96-well plate, and the plate was placed in 95% NO2 
and 5% CO2. The plates were incubated for 20 h and a further 24 h at 
37°C. Bacteria that were attached to the 96-well plate were rinsed with 
100 µL phosphate-buffered saline (PBS).
Exposure of breadfruit leaf extract and MTT test
In each well plate that was washed with PBS, 100 µl of the breadfruit 
leaf extract was added at various concentrations (5%, 10%, 20%, 40%, 
80%, and 100%) to each well plate. For the positive control, 100 µL 
of 0.1% chlorhexidine (0.2% chlorhexidine mixed with BHI 1:1) was 
added to each well. For the negative control, BHI broth was added to 
each well. The well plate was inserted into an anaerobic jar with 90% 
NO2 and 5% CO2 and was incubated for 2 h at 37°C. The MTT test was 
performed by adding 50 µL into 96-well plate and incubated for 3 h at 
37°C. Then, 100 µL of acidified isopropanol was added into each well 
and the plate was observed on a microplate reader at a wavelength of 
490 nm. The percentage of biofilm viability was examined using the 
following formula:
 
OD value of treated groupViability = ×100%
OD value of control group
Data analysis
The percentage of each S. mutans treated group viability was tested 
using one-way analysis of variance.
RESULTS
The normality test, Kolmogorov–Smirnov, showed that the data had a 
normal distribution (p>0.05)
In the accumulation phase (20 h), the viability of S. mutans control 
group was 100% (OD, 1.541±0.035) (Fig. 1). 0.1% chlorhexidine 
positive control group had a viability of 9% (OD, 0.137±0.010) (Fig. 1). 
In the breadfruit leaf extract exposure group, at 5% concentration, the 
viability was 82% (OD, 1.265±0.023). In 10% concentration group, 
the  viability was 79% (OD, 1.217±0.038); in 20% concentration 
group, the viability was 56% (OD, 0.867±0.037); in 40% concentration 
group, the viability was 50% (OD, 0.44±0.016); in 80% concentration 
group, the viability was 36% (OD, 0.77±0.038); and in 100% 
concentration group, viability was 29% (OD, 0.561±0.031) (Fig. 1). 
S. mutans viability declined with increasing concentration of the 
breadfruit leaf extract in the accumulation phase (Fig. 1). All the treated 
groups significantly differed from the control group (*p<0.05).
In the maturation phase (24 h), the viability of S. mutans control group 
was 100% (OD, 0.953±0.061) in the negative control group and 18% 
(OD, 0.173±0.010) in 0.1% chlorhexidine positive control group (Fig. 2). 
In the breadfruit leaf extract exposure group, at 5% concentration, 
S. mutans viability was higher than the control group of 117% (OD 
1, 119±0.054). S. mutans viability was 92% (OD, 0.877±0.059) at a 
concentration of 10%, 79% (OD, 0.755±0.039) at a concentration of 
20%, 68% (OD, 0.647±0.032) at a concentration of 40%, 65% (OD, 
0.621±0.027) at a concentration of 80%, and 59% (OD, 0.566±0.047) 
at a concentration of 100% (Fig. 2). S. mutans viability declined with 
increasing concentration of the breadfruit leaf extract in the maturation 
phase. All treated groups significantly differed from the negative control 
group (*p<0.05).
S. mutans biofilm viability in 0.1% chlorhexidine group in the 
accumulation phase was lower than that in the maturation phase 
(Fig. 3). The same results were observed for the groups exposed to 
different concentrations of the breadfruit leaf extract (Fig. 3). There 
was a significant decrease in S. mutans viability in the accumulation 
phase compared with that in the maturation phase.
DISCUSSION
Breadfruit leaf extract at concentrations of 5%, 10%, 20%, 40%, 80%, 
and 100% decreased S. mutans biofilm viability during the accumulation 
phase (20 h) (Fig. 1). During the maturation phase, breadfruit leaf 
extract at a concentration of 5% significantly increased the S. mutans 
biofilm viability (Fig. 2).
Based on research conducted by Purnamasari et al., antibacterial effects 
are stronger with higher concentrations of cocoa seed extract due to 
the greater active compound content of the extract [10]. Breadfruit leaf 
contains active compounds such as flavonoid, polyphenol, quinone, 
steroid, saponin, monoterpene, and sesquiterpene [8]. Kusdarwati’s study 
on the antibacterial effect of the adas fruit extract (Foeniculum vulgare) on 
Micrococcus luteus bacteria found that the flavonoid compounds saponin 
and tannin are antibacterial phenolic compounds that have the same 
chemical structure within plants. The compound exerts its antibacterial 
mechanism by denaturing the bacterial wall protein so that bacterial 
metabolism is inhibited, resulting in low bacterial growth [11]. This study 
differed from the previous study in the use of breadfruit leaf and adas 
fruit extract. Trijani’s study found that if the antibacterial concentration 
was low, phenol compounds would easily decompose and lead to leakage 
of bacterial walls. At high concentrations, phenol compounds cause 
bacterial cell membranes lysis [12].
At the maturation phase, breadfruit leaf extract at a concentration 
of 5% increased S. mutans viability (Fig. 2). Based on the research 
conducted by Sabir, in the maturation phase, antibacterial compounds 
at low concentrations would effectively inhibit the growth of S. mutans 
when applied continuously [13]. If they are not applied continuously, it 
is recommended to use high concentrations [13].
Fig. 1: Streptococcus mutans biofilm viability during the accumulation phase (20 h) after exposure to breadfruit leaf extract
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This result may be influenced by the extracellular matrix of bacteria 
found on biofilms so it will limit the penetration of antibacterial 
agents. The thicker the biofilm, the more slowly the antibacterial 
compound diffuses into the biofilm, thus causing the occurrence of 
antibacterial resistance at the maturation phase [14]. We found that 
in the maturation phase, the breadfruit leaf extract was not capable of 
reducing S. mutans viability. Factors that may affect the antibacterial 
activity are environmental pH, seed components, active substance 
stability, and bacterial metabolic activity [15].
In the maturation phase, there can be a reduction in the bacterial 
activity during the process of biofilm formation due to nutritional 
deficiency [5]. Based on the research conducted by Hidayaningtias, 
viability would increase in the maturation phase if bacteria were given 
a medium for growth [16]. In this study, the breadfruit leaf extract was 
mixed with BHI broth. At 5% breadfruit leaf extract concentration, 
the amount of BHI broth was higher than the amount of breadfruit 
leaf extract; therefore, the antibacterial compound could not work 
optimally. As a result, the biofilm viability increased.
The positive control used in this study was 0.1% chlorhexidine, which 
prevents caries by inhibiting plaque formation [15]. Rachmawati stated 
that the antibacterial effect of temulawak ethanol extract on S. mutans 
biofilm was equivalent to that of chlorhexidine [16]. In this study, 
S. mutans viability when exposed to breadfruit leaf extract was higher 
than that with 0.1% chlorhexidine.
The results of the MTT test with breadfruit leaf extract exposure at 
various concentrations demonstrated that S. mutans viability in the 
accumulation phase was lower than that in the maturation phase (Fig. 3). 
Based on the research conducted by Hojo, antibacterial compounds 
effectively inhibit the growth of bacteria in the accumulation phase [10]. 
In the accumulation phase, the microorganisms have a solid matrix 
structure, which is primarily composed of polysaccharide. According to 
the study conducted by Rachmawati et al., the Gram-positive cell wall 
structure is more simple and single layered with a low lipid content of 
1%–4% that allows bioactive materials into cells [17].
CONCLUSION
In the accumulation phase, breadfruit leaf extract at concentrations 
of 5%, 10%, 20%, 40%, 80%, and 100% can reduce S. mutans 
biofilm viability. In the maturation phase, breadfruit leaf extract at 
concentrations of 10%, 20%, 40%, 80%, and 100% can reduce S. mutans 
biofilm viability. S. mutans biofilm viability in the accumulation phase 
was lower than that in the maturation phase for all exposure groups. S. 
mutans viability at 5% breadfruit leaf extract concentration increased 
in the maturation phase.
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